Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan D Carabenciov

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Oncology|March 16, 2019
Controversies in the Therapy of Low-Grade GliomasIvan D Carabenciov, Jan C Buckner
Mayo Clinic Proceedings|March 26, 2018
Safety of Lumbar Puncture Performed on Dual Antiplatelet TherapyIvan D Carabenciov, Maximiliano A Hawkes, Sara Hocker
Mayo Clinic Proceedings|February 4, 2019
Amantadine Use for Postconcussion SyndromeIvan D Carabenciov, Britta L Bureau, Michael Cutrer, et al.
The Neurologist|May 3, 2019
Bevacizumab Use in Refractory Adult Pilocytic Astrocytoma: A Single-Center Case SeriesIvan D Carabenciov, Adip G Bhargav, Joon H Uhm, et al.
The Neurologist|December 2, 2021
Temporal Trends in Glioblastoma Survival: Progress then PlateauBryan J Neth, Ivan D Carabenciov, Michael W Ruff, et al.
Neurocritical Care|February 14, 2018
Critical West Nile Neuroinvasive DiseaseMaximiliano A Hawkes, Ivan D Carabenciov, Eelco F M Wijdicks, et al.
Critical Care Medicine|July 10, 2018
Outcomes in Patients With Severe West Nile Neuroinvasive DiseaseMaximiliano A Hawkes, Ivan D Carabenciov, Eelco F M Wijdicks, et al.
The Neurohospitalist|November 15, 2024
Primary Diffuse Leptomeningeal GliomatosisHannah Padilla, Michael D Liu, Reece M Hass, et al.
The Neurologist|May 27, 2024
A Case of Long-Term Survival After Glioblastoma, IDH-Wild TypeLauren M Webb, Bryan J Neth, Aditya Raghunathan, et al.
Journal of Neuro-Oncology|January 25, 2022
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experienceBryan J Neth, Samantha N Balakrishnan, Ivan D Carabenciov, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Oncology|March 16, 2019
Controversies in the Therapy of Low-Grade GliomasIvan D Carabenciov, Jan C Buckner
Mayo Clinic Proceedings|March 26, 2018
Safety of Lumbar Puncture Performed on Dual Antiplatelet TherapyIvan D Carabenciov, Maximiliano A Hawkes, Sara Hocker
Mayo Clinic Proceedings|February 4, 2019
Amantadine Use for Postconcussion SyndromeIvan D Carabenciov, Britta L Bureau, Michael Cutrer, et al.
The Neurologist|May 3, 2019
Bevacizumab Use in Refractory Adult Pilocytic Astrocytoma: A Single-Center Case SeriesIvan D Carabenciov, Adip G Bhargav, Joon H Uhm, et al.
The Neurologist|December 2, 2021
Temporal Trends in Glioblastoma Survival: Progress then PlateauBryan J Neth, Ivan D Carabenciov, Michael W Ruff, et al.
Neurocritical Care|February 14, 2018
Critical West Nile Neuroinvasive DiseaseMaximiliano A Hawkes, Ivan D Carabenciov, Eelco F M Wijdicks, et al.
Critical Care Medicine|July 10, 2018
Outcomes in Patients With Severe West Nile Neuroinvasive DiseaseMaximiliano A Hawkes, Ivan D Carabenciov, Eelco F M Wijdicks, et al.
The Neurohospitalist|November 15, 2024
Primary Diffuse Leptomeningeal GliomatosisHannah Padilla, Michael D Liu, Reece M Hass, et al.
The Neurologist|May 27, 2024
A Case of Long-Term Survival After Glioblastoma, IDH-Wild TypeLauren M Webb, Bryan J Neth, Aditya Raghunathan, et al.
Journal of Neuro-Oncology|January 25, 2022
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experienceBryan J Neth, Samantha N Balakrishnan, Ivan D Carabenciov, et al.
Pageof 2